Loading...
NPI 1326256918 · Little Rock, AR · Retina Specialist (Ophthalmology) Physician
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Stephen Davis is a retina specialist (ophthalmology) physician provider located in Little Rock, Arkansas. This profile covers 23 Medicare and 1 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Individual |
| Organization | Stephen Davis |
| Address | 9800 Baptist Health Dr |
| City | Little Rock |
| State | AR |
| ZIP | 72205 |
| Taxonomy | Retina Specialist (Ophthalmology) Physician |
| NPI Enumerated | May 18, 2007 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $2.5M |
| Medicaid | $4.7K |
This provider is a retina specialist (Ophthalmology) with a long active enrollment (NPI enumerated 2007-05-18, ~19 years ago) and a clear payer concentration: lifetime Medicare revenue is $2.5M versus lifetime Medicaid revenue of $4.7K, indicating the practice is effectively Medicare-dominant in scale. The small Medicaid footprint relative to Medicare suggests the panel is skewed toward older, Medicare-eligible patients rather than Medicaid populations.
Medicare revenue is highly concentrated in injection and related procedure codes: the precomputed top 3 Medicare codes (J0178, J2777, 67028) account for 80.1% of the provider’s total Medicare revenue. Primary drivers are J0178 ($1.2M, 45.8% of Medicare revenue) and J2777 ($729.1K, 29.0% of Medicare revenue), with 67028 contributing $133.5K (5.3%).
The code mix and volumes point to a clinic-centered medical retina operation focused on intravitreal pharmacotherapy and retinal monitoring: J0178 (injection, aflibercept) and J2777 (injection, faricimab) are the top revenue contributors and are supported by high-volume imaging like 92134. Procedural codes for injections (67028) and multiple intravitreal drug codes (including J2778, J2781, J7312) reinforce that in-office drug administration and follow-up imaging are core service lines rather than a primarily surgical retinal practice.
While anti-VEGF and related drug codes are the dominant revenue drivers, the provider’s competitive standing differs by service line. For drug administration J0178 ranks #707 of 3204 nationally (78th percentile; typical, unremarkable volume) and J2777 ranks #384 of 2039 nationally (81th percentile; typical, unremarkable volume), indicating solid but not outsized national market share for injections. By contrast, 92134 (retinal computerized diagnostic imaging) is an outlier: it ranks #437 of 26868 nationally (98th percentile; extreme outlier, far above typical national volume), showing the provider is far above typical peers on imaging activity.
Several evaluation and imaging codes also show unusually high national standing, consistent with heavy diagnostic throughput. 92012 has 1.2K claims and $68.6K revenue and ranks #301 of 17177 nationally (98th percentile; extreme outlier, far above typical national volume), and 99204 has 246 claims and $25.8K revenue and ranks #2551 of 227068 nationally (99th percentile; extreme outlier, far above typical national volume). These patterns suggest significant clinic visit volume for intermediate and new patient evaluations in addition to procedure visits.
Surgical retina codes are present but represent a small share of Medicare revenue, indicating a primarily medical-retina/injection-focused practice with occasional surgeries. For example, 67039 shows 28 claims and $18.5K revenue and ranks #22 of 121 nationally (81th percentile; typical, unremarkable volume), while other vitrectomy and membrane procedures have low counts and small revenue shares, consistent with episodic surgical work rather than a high-volume surgical retina center.
On Medicaid, the provider’s entire reported Medicaid revenue ($4.7K) is concentrated in a single code: 92134 (124 claims, $38 avg paid/claim), which accounts for 100.0% of Medicaid revenue and ranks #30 of 43 in-state (31th percentile; typical, unremarkable volume). Despite being an extreme outlier on Medicare imaging, the provider is not a major Medicaid retinal imaging provider in-state, underscoring a payer mix and patient demographic that heavily favors Medicare beneficiaries.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
23 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | 1,670 | $690 | $1.2M |
| J2777 | Injection, faricimab‑svoa, 0.1 mg | 25,140 | $30 | $729.1K |
| 67028 | The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye. | 1,760 | $80 | $133.5K |
| J2778 | Injection, ranibizumab, 0.1 mg | 510 | $180 | $91.9K |
| 92134 | The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes. | 2,940 | $30 | $76.4K |
| 92012 | For this CPT code, an Ophthalmologist sees an established patient for an intermediate level eye examination. Generally, a patient is considered to be "established" if the same physician, or any… | 1,200 | $60 | $68.6K |
| 92014 | An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group… | 790 | $80 | $60.2K |
| J3490 | Unclassified drugs | 20 | $1,690 | $37.2K |
| J2781 | Injection, pegcetacoplan, intravitreal, 1 mg | 300 | $120 | $36K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 250 | $110 | $25.8K |
Showing 1–10 of 23
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 23 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
23 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| J0178 | 5 | 30 | 390 | $690 | $538.3K |
| J2777 | 6 | 20 | 12,180 | $30 | $504.5K |
| J2778 | 3 | 20 | 270 | $180 | $85K |
| J2781 | 3 | 10 | 330 | $120 | $75.8K |
| 67028 | 5 | 40 | 270 | $80 | $51.1K |
| J7312 | 5 | 10 | 190 | $160 | $42.6K |
| J7999 | 4 | 30 | 100 | $130 | $20.6K |
| 92014 | 32 | 370 | 150 | $70 | $19.1K |
| 67039 | 1 | 10 | 30 | $650 | $18.2K |
| 67041 | 4 | 10 | 20 | $810 | $17.1K |
Showing 1–10 of 23
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
1 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 92134 | The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes. | 120 | $40 | $4.7K |
How this provider's Medicaid billing volume and revenue compare to other Arkansas providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Arkansas median
1 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 92134 | The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes. | 30 | 40 | 260 | $20 | $26.2K |
Other providers in the same ZIP code as Stephen Davis, ranked by combined Medicare and Medicaid revenue.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.